GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage ...

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has ...

British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine ...

LONDON, UK I 12, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal ...

With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...

In Australia, our process differs slightly and tends to take a little longer. The TGA’s website indicates applications for ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

GSK announced positive Phase II results for its mRNA seasonal influenza vaccine, showing strong immune responses against ...

GSK announced promising results from its phase two clinical trial for an mRNA-based seasonal flu vaccine on Thursday.

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...